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Abstract
The ribosome is a unique machine for protein synthesis in organisms. The construction of
ribosomes is exceedingly complex and consumes the majority of the cell materials and
energy. The materials for ribosome production are supplied by nutrients. Therefore, the
production of ribosomes is restricted by environmental nutrients, and cells need mecha-
nisms to control ribosome production in order to reconcile demands for cell activities with
available resources. Transcription of ribosomal RNA is an essential step in ribosome biogen-
esis. It strongly affects the total amount of ribosome production, and thus rapidly growing
cells have an elevated level of ribosomal RNA transcription. Ribosomal RNA transcription
is controlled by many mechanisms, including the efficiency of preinitiation complex forma-
tion for RNA polymerase I (Pol I) and epigenetic marks in ribosomal RNA genes. These are
affected by cell cycle progression, signal transduction pathways, cell-damaging stresses,
nutrients such as glucose, and the metabolites. Recent studies also suggest that the epige-
netic marks, acetylation and methylation, may be not only controlled by nutrients but also
function as reservoirs for biological resources in chromatin. Further studies would provide
information about the mechanisms cells use to adjust production of cellular components to
available resources and clues for developing novel anti-cancer treatments.
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1. Introduction
The ribosome is a unique machine for synthesizing protein in organisms. Protein synthesis is
essential for all biological events, and the quantity of ribosomes substantially affects all biolog-
ical activities. Rapidly growing cancer cells require synthesis of much protein and thus many
ribosomes. In vertebrates, a ribosome consists of about 80 proteins and 4 structural ribosomal
RNAs (rRNAs): 5S rRNA, 5.8S rRNA, 18S rRNA, and 28S rRNA [1, 2]. The construction
processes are exceedingly complex and include rRNA transcription, rRNA processing,
© 2018 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
synthesis of ribosome proteins and regulatory proteins, assembly of rRNAs and ribosome
proteins, and maturation of the ribosome (Figure 1). The entire process consumes up to 80%
of the cell’s materials [3, 4], and 80% of the energy to proliferate cells [4, 5]. The materials for
ribosome production are supplied by nutrients that are taken up from the environment.
Therefore, the production of ribosomes is restricted by environmental conditions, and cells
Figure 1. Processes of ribosome construction. Ribosomal RNA transcription, processing, and association of ribosomal
proteins occur in the nucleolus. Mature ribosome functions in the cytoplasm. The process is outlined in the yellow box on
the right side of this figure. Ribosomes contain four structural ribosomal RNAs (rRNAs): 5S rRNA, 5.8S rRNA, 18S rRNA,
and 28S rRNA. The first step of ribosome construction is transcription of ribosomal RNA (rRNA) from the ribosome RNA
gene (rDNA) repeating units in the nucleolus. RNA polymerase I (Pol I) transcribes pre-rRNA, which is processed to three
structured rRNAs (18S, 28S and 5.8S rRNA). 5S rRNA is synthesized by RNA polymerase III. In the mature ribosome, 18S
rRNA is contained in the 40S ribosome (small subunit of ribosome), and 28S, 5.8S, and 5S rRNAs are contained in the 60S
ribosome (large subunit of ribosome). Ribosomal protein assembly, rRNA processing, and maturation occur in the
nucleolus, and ribosomes are exported to the cytoplasm and perform the translation activity.
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should have control of the mechanisms of ribosome production in order to reconcile demands
for cell activities with the available biological resources.
Three of the four structured rRNAs (18S, 28S, and 5.8S rRNA) constituting ribosomes are
produced by processing of a precursor transcript, pre-ribosomal RNA (pre-rRNA). The pre-
rRNA is coded by rRNA genes (rDNA) and specifically transcribed by RNA polymerase I (Pol
I) in the nucleolus. Because a single copy of rDNA is not sufficient to supply the number of rRNA
molecules required, there are 100–300 copies of tandemly repeated rDNAs per haploid genome
in mammals. Paradoxically, only half the copies of rDNA are in transcriptionally active forms
and the rest are silent, which may provide a control step for rRNA transcription [6–9]. The
transcription of rRNA is an essential step in ribosome biogenesis and affects the total number
of ribosomes produced. It was suggested that 75% of total RNAs constitute rRNAs in Hela cells
[10], and the rRNA transcription represents about 35% of all transcripts in proliferating cells [6],
showing that rRNA synthesis uses a lot of materials. Therefore, the control of rRNA transcrip-
tion plays a role in maintaining homeostasis in biological resources. In this review, we describe
the control of rRNA transcription by various factors such as the cell cycle regulators, signal
transduction pathways, growth factors, tumor-related proteins, and cell-damaging stresses.
Then, we will discuss the control mechanisms of rRNA transcription in response to nutrients.
Figure 2. Pre-initiation complex for RNA polymerase I and rRNA processing. The basic composition of the pre-initiation
complex (PIC) for RNA polymerase I is illustrated. PIC is assembled on the rDNA promoter by synergistic action of the
upstream binding factor (UBF), which is bound at the upstream control element (UCE), selective factor 1 (SL1), which is
bound to the core promoter through TATA-box binding protein (TBP), transcription initiation factor IA (TIF-IA), and
RNA polymerase I (Pol I). SL1 contains TBP and Pol I-specific TBP-associated factors (TAFIs: TAFI110, TAFI68, TAFI48,
TAFI41, and TAF12). SL1 on the core promoter recruits RNA polymerase I through TIF-IA, which associates with both
components of Pol I and SL1. After the completion of PIC formation, Pol I is released from the promoter by regulation of
TIF-IA and starts to transcribe pre-rRNA. This release is the initiation step of rRNA transcription. Pre-rRNA is processed
to structured rRNA, 18S, 5.8S, and 28S rRNA to construct ribosomes.
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2. Formation of preinitiation complex (PIC) on rDNA promoter
The first step of rRNA transcription is the formation of the preinitiation complex (PIC) on the
rDNA promoter. The upstream binding factor (UBF), the promoter selective factor 1 (SL1),
transcription initiation factor IA (TIF-IA), and RNA polymerase I (Pol I) synergistically assem-
ble at the rDNA promoter to form PIC (Figure 2). While the name SL1 is used for human
proteins, that for mice is transcription initiation factor 1B (TIF-IB). UBF and SL1 bind to an
upstream control element (UCE) and the core promoter region of rDNA, respectively. SL1
recruits Pol I through TIF-IA, and UBF stabilizes the binding of SL1 to Pol I at the rDNA
promoter [6, 11].
SL1 is a protein complex consisting of TATA-box binding protein (TBP), Pol I-specific TBP-
associated factors (TAFIs), including TAFI110, TAFI68, and TAFI48, which were originally
identified with TBP as essential transcriptional factors by an in vitro transcription assay [12].
TBP is not only a Pol I-specific factor, but also used for transcription by RNA polymerase II and
III. Later, TAFI41 and TAF12 were identified as members of the TAFIs. TAF12 was originally
reported as a transcription factor for RNA polymerase II [13]. One activity of TBP is binding to
the TATA box in the core promoter to recruit SL1 complex. TIF-IA binds to the RPA43 subunit
of Pol I complex and TAFI110, TAFI68, and TAFI41 of the SL1 complex. These binding activities
are essential for TIF-IA to recruit Pol I to the promoter bound by SL1 to facilitate PIC formation
on the rDNA promoter. The formation of PIC is controlled by various factors (Figure 3). When
Pol I starts the rRNA transcription, the interactions forming PIC are disrupted. This disruption
is the initiation step of transcription, one of the control mechanisms.
Figure 3. Factors regulating PIC formation. The PIC for Pol I transcription is controlled by various factors, including cell
cycle signals, signal transduction pathways, stress signals, oncoprotein/tumor suppressors, and others. The classes of
regulatory factors are expressed with specific color boxes as indicated in the box on the right. UBF is activated by cdk
family proteins, ribosomal protein S6 kinase (S6K), casein kinase II (CK2), and CBP, and is repressed by the Rb/HDAC
complex. SL1 is activated by c-Myc, PCAF, and cdc14B, and repressed by p53, SIRT1,cdc2/cyclin B, CK2, PTEN, and
GSK3β. TIF-IA is activated by ERK1/2, RSK, mTOR, and CK2 (activated by Akt), and repressed by JNK2 and AMPK.
RNA polymerase I (Pol I) is activated by SIRT7 and CBP.
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3. Control of rRNA transcription during cell cycle progression
The activities of all classes of RNA polymerases are controlled during the cell cycle progres-
sion [14, 15]. The cell cycle regulator cyclin/cdk complexes control the level of rRNA tran-
scription (Figure 3). In the M phase, SL1 is inactivated by cdk1/cyclin B (cdc2/cyclin B)
through phosphorylation of TAFI110 to silence rRNA transcription [16, 17]. On exiting
mitosis, the phosphorylation in TAFI110 is removed by cell division cycle 14B (Cdc14B)
[18]. Additionally, mitotic repression of rRNA transcription correlates with the hypo-
acetylation of TAFI68 caused by Sirtuin 1 (SIRT1). The hypo-acetylation makes SL1 instable
on binding to the rDNA promoter [18]. It was also reported that the site of deacetylation of
TAFI68 by SIRT1 is acetylated by p300/CBP-associated factor (PCAF), which is correlated
with the activation of rRNA transcription [18].
After mitosis, rRNA transcription is re-activated by G1/S-specific cyclins (cdk4/cyclin D, cdk2/
cyclin E, cdk2/cyclin A) through phosphorylation of UBF on the specific sites (cdk4/cyclin D
(S484), cdk2/cyclin E (S388, S484), cdk2/cyclin A (S388): in mouse) [19, 20].
4. Signal transduction pathways control rRNA transcription
Protein synthesis is required for cell growth, and the signal transduction pathways that affect
cell growth, including phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin
(mTOR) signaling and ERK (MAPK) signaling, are involved in the regulation of rRNA tran-
scription (Figure 3).
The PI3K-AKT-mTOR signal pathway is stimulated by binding of insulin/Insulin-like growth
factors (IGF) to their cognate receptors on the cell surface. AKT activates rRNA transcription
through the phosphorylation of CK2. CK2 regulates rRNA transcription at multiple levels by
affecting the formation of PIC, initiation, elongation, and reinitiation, through phosphorylation
of several proteins including UBF, TAFI110 (SL1), and TIF-IA [21–26]. mTOR activates rRNA
synthesis by translocating TIF-IA into the nucleolus using kinase activity [27]. The ribosomal
protein S6 kinase (S6K), which is a downstream kinase of mTOR, also activates rRNA synthe-
sis through regulation of UBF-SL1 interaction by phosphorylation of UBF. The mTOR activity
also enhances the expression of UBF [28]. SNF2 histone linker PHD RING helicase (SHPRH),
which was identified as a RAD5 homolog and known as E3 ubiquitin-protein ligase, binds to
rDNA promoters using its PHD domain and promotes recruitment of Pol I to rDNA (Figure 4).
This activation of rRNA transcription by SHPRH is inhibited in an mTOR-dependent manner
[29]. K-demethylase 4A (KDM4A)/JMJD2A activates rRNA transcription on serum stimulation
(Figure 4). This activation is mediated through the PI3K/serum/glucocorticoid regulated
kinase 1 (SGK1) signaling cascade independent of the AKT pathway. SGK1 is one of the
downstream kinases of PI3K signaling. The serum-stimulated KDM4A decreases a repressive
histone H3K9me3 mark modification in rDNA to activate rRNA transcription [30]. In mouse
adipocytes, polymerase I transcription and release factor (PTRF)/Cavin-1 promotes rRNA
transcription, which is induced by insulin and repressed by fasting (Figure 4). The stimulation
of rRNA transcription by PTRF is mediated by the formation of the transcription loop that
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links the transcriptional start sites and termination sites. The formation may enhance transcrip-
tional reinitiation [31].
The binding of epidermal growth factor (EGF) or its related ligands to their cognate recep-
tors on the cell surface stimulates a signaling cascade including the GTPase Ras, the kinases
Raf, MAP kinase-ERK kinase (MEK), and extracellular signal-regulated kinase (ERK). ERK
activates rRNA transcription through phosphorylation of UBF in the promoter [32] and
gene body regions [33] (Figure 3).This phosphorylation decreases the binding capacity of
UBF to rDNA. In this case, it was reported that the dissociation of UBF from rDNA
enhances Pol I release from the promoter, leading to activation of rRNA transcription.
Additionally, ERK/90 kDa ribosomal S6 kinase (RSK) phosphorylates TIF-IA to activate rRNA
transcription [34] (Figure 3). It is still unclear how the phosphorylation by RSK induces rRNA
transcription.
Figure 4. Signal transduction pathways under growth factor controlled rRNA transcription. Growth factors including
insulin, insulin-like growth factor (IGF-1), epidermal growth factor (EGF), and unidentified serum factors (Serum) control
rRNA transcription through signal transduction pathways, such as PI3K/mTOR, PI3K/SGK and ERK1/2, which control
PIC components (SL1, TIF-IA, and Pol I), transcription factors (PTRF/Carvin-1, c-Myc and SHPRH) or chromatin/nucleo-
some regulators (lncRNA, NuRD, and KDM2B).
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Elevation of the concentration of calcium ions (Ca2+) in the cytoplasm stimulates the signaling
pathway of calcium/calmodulin-dependent protein kinase II (CaMKII). The stimulated CaMKII
activates S6K, which phosphorylates UBF to activate rRNA transcription in colorectal cancer
(CRC) (Figure 3). In CRC, the function of adenomatous polyposis coli (APC) gene is frequently
lost and the level of Ca2+ is increased in the cells [35].
5. Control of rRNA transcription by unidentified serum factors
Serum, used to supplement the cell culturing medium, contains many factors that control
rRNA transcription. Although all factors and signal cascades are not completely identified,
they perform critical functions in the regulation of rRNA transcription (Figure 4).
Depletion of serum from a culture medium represses rRNA transcription. c-Myc plays a critical
role for cell growth and proliferation in many types of cells, and is deregulated and over-
expressed in tumor cells. c-Myc associates with the promoter and transcribed regions of rDNA
and activates rRNA transcription in response to serum stimulation [36].
K-demethylase 2B (KDM2B)/JHDM1B is bound to rDNA to repress rRNA transcription. The
repression is associated with the demethylation of trimethylated lysine 4 on histone H3
(H3K4me3) by KDM2B. Serum starvation increases the recruitment of KDM2B on rDNA, and
resupply of serum decreases it. These data suggest that the activity of KDM2B in controlling
rRNA transcription is regulated by serum factors [37].
The specific long non-coding RNAs (lncRNAs) are induced during periods of quiescence, such as
serum starvation, and increase the level of histone H4K20me3 on the rDNA promoter in a
suppressor of variegation 4-20 homolog (Suv4-20 h)-dependent manner. The elevated level of
H4K20me3 leads to chromatin compaction. The lncRNAs are antisense transcripts against rDNA,
are termed the promoter and pre-rRNA antisense (PAPAS), and associated with rDNA [38].
A chromatin remodeling complex, nucleosome remodeling deacetylase (NuRD), establishes
the poised state of rDNA through regulation of histone modifications and nucleosome posi-
tions. The level of the state of rDNA is increased in the growth-arrested conditions induced by
serum starvation and differentiation [39].
6. Oncoprotein and tumor suppressors in rDNA transcription
Tumor cells show abnormal growth that is thought to be associated with the elevation of
ribosome biogenesis, and regulation of rRNA transcription by oncogenes and tumor-suppressor
genes was reported.
The oncoprotein c-Myc is the product of oncogene c-myc, and its expression is stimulated by
serum and associated with rRNA transcription [36] (Figure 4 and Section 5). It was reported
that c-Myc binds to the sites with the consensus sequences on rDNA and stimulates rRNA
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transcription [40]. c-Myc is also reported to control the PIC factors such as UBF and ribosomal
proteins [41–43]. Therefore, c-Myc activates ribosome biogenesis at multiple steps [3, 44, 45] .
The rb gene is a tumor-suppressor gene. Rb protein binds to UBF, which may be related to
restriction of cell proliferation by Rb [46]. The binding of Rb to UBF inhibits the binding of UBF
to rDNA [47] or inhibits the binding of UBF to SL1 [48], both of which result in the repression
of rRNA transcription (Figure 3). Another report suggested that phosphorylated Rb (pRb)
creates a complex with histone deacetylase (HDAC) and decreases the acetylation of UBF to
repress rRNA transcription [49]. In this study, it was also reported that the acetylation in UBF
is modified by CREB-binding protein (CBP) (Figure 3).
A tumor-suppressor gene, p53, is frequently mutated in tumors, and p53 protein represses
rRNA transcription through prevention of the interaction between SL1 and UBF [50] (Figure 3).
The phosphatase and tensin homolog deleted from chromosome 10 (PTEN) is known as a
tumor suppressor. PTEN represses rRNA transcription by disrupting the SL1 complex in its
lipid phosphatase activity-dependent manner [51] (Figure 3). It was also reported that PTEN is
phosphorylated by glycogen synthase kinase (GSK) 3β [52]. GSK3β and PTEN are selectively
enriched in the nucleoli of RAS-transformed cells and associate with the promoter and coding
region of the rDNA [53]. An activated GSK3β mutant abolishes rRNA transcription and
associates with TAFI110 in the SL1 complex [53]. These results suggest a repressive function
for GSK3β on rRNA transcription that supports its role as a tumor suppressor.
7. Controls of rRNA transcription by cell-damaging stresses
A variety of stresses such as UV, ionizing radiation, heat shock, and osmotic shock attack cellular
vital components like DNA, proteins, and lipid membranes. These stresses also affect rRNA
transcription.
c-Jun N-terminal kinase (JNK) phosphorylates c-Jun at the NH2-terminal Ser63 and 73 residues
in response to UV irradiation and other stress stimuli [54]. JNK2 inactivates rRNA transcription
through phosphorylation of TIF-IA to inhibit its function of bridging between Pol I and SL1
[55] (Figure 3).
The DNA damage caused by ionizing radiation also induces the repression of rRNA transcrip-
tion through other pathways, which involves Nijmegen breakage syndrome protein 1 (NBS1)-
treacle, Ataxia Telangiectasia Mutated (ATM), and breast cancer susceptibility gene I (BRCA1).
In the presence of double strand breaks induced by ionizing radiation, NBS1 translocates and
accumulates in nucleoli in a treacle-dependent manner to silence rRNA transcription [56]. The
treacle gene was found to be mutated in Treacher Collins syndrome, which is characterized by
deformation of bones and other tissues in the face. ATM-dependent signaling was shown to
shut-down rRNA transcription in response to chromosome breaks [57]. BRCA1, known as a
tumor suppressor, was reported to interact with UBF, SL1, and Pol I. In response to DNA
damage, BRCA1 bound to rDNA is dissociated, and induces instability of Pol I on rDNA to
repress rRNA transcription [58].
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Heat shock at 42C represses rRNA transcription through the inactivation of TIF-IA by inhibition
of CK2-dependent phosphorylation of TIF-IA and the lncRNAs PAPAS-dependent nucleosome
regulation by NuRD complex [59]. Hypotonic stress represses rRNA transcription through
upregulation of PAPAS to trigger nucleosome repositioning by NuRD [60]. In these conditions,
Suv420h2 was neddylated and the levels of Suv420h2 and H4K20me3 marks were increased.
However, the relationship between PAPAS and Suv420h2 was not clear. Cytoskeletal stress,
which is related to cell shape, represses rRNA transcription through Rho-associated protein kinase
(ROCK). ROCK is one of the kinases of myosin and induces recruitment of HDAC on rDNA,
resulting in deacetylation of histone acetylated lysine 9 and 14 on histone H3 (H3K9/14) [61].
8. Control of rRNA transcription by nutrients
Cells obtain biological resources for cellular activities from their environment. The sensing of
environmental nutrients is important for efficient usage of nutrients and maintaining cells. In
murine intestinal epithelium, apical transcripts are more efficiently translated, because ribo-
somes were more abundant on the apical sides. Refeeding of fasted mice induces a basal to
apical shift of mRNAs encoding ribosomal proteins, which is associated with an increase in
their translation and increased protein production. These mechanisms allow efficient nutrient
absorption in response to the rich conditions, although the molecular mechanisms are not clear
[62]. It was shown that mTOR senses the levels of amino acids, especially leucine, in cells, and
controls the translation activity through regulation of the eukaryotic translation initiation
factor 4E binding protein (4E-BP)-eukaryotic translation initiation factor 4E (elF4E) axis and
p70 S6K-S6 axis [4, 63, 64]. Recently, increasing evidence shows the presence of specific
mechanisms to control rRNA transcription in response to nutrients (Figure 5).
8.1. Amino acids
The starvation of amino acids affects the frequency of initiation of nucleolar RNA polymerase,
which was later established to be an rRNA transcription by Pol I [65]. The starvation of amino
acids decreases the interaction of TIF-IA with SL1 and Pol I [66]. As described above in Section
4, mTOR controls rRNA transcription, and is important for regulation of rRNA transcription in
response to amino acid levels. Amino acid starvation inhibits the activity of mTOR and its
downstream kinase S6K. mTOR and S6K control TIF-IA and UBF, respectively, to regulate
rRNA transcription [27, 67].
c-MYC is also involved in regulation of rDNA transcription in response to starvation of amino
acids. Although translation of c-Myc is reported to be controlled by mTOR signaling [68, 69],
the stabilization of c-Myc in response to amino acid starvation is controlled by an mTOR-
independent pathway [70].
8.2. Guanosine triphosphate (GTP)
It was reported that the sizes of ATP and GTP intracellular pools affect the level of nucleolar
RNA synthesis (rRNA transcription) [71]. Recently, the consensus sequences for GTP binding
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were identified in TIF-IA [72], and the binding of TIF-IA to GTP is required for the interaction
of TIF-IA with ErbB3-binding protein (Ebp1). Ebp1 controls ribosomal biogenesis when
located in the nucleolus [73]. Therefore, the level of GTP appears to be sensed by TIF-IA to
affect rRNA transcription (Figure 5).
8.3. Glucose
The major energy source for cells is glucose. Glucose is used to synthesize ATP. ATP is
essential for most biological activities, including ribosome biogenesis. Several studies demon-
strated that the levels of glucose and ATP production affect rRNA transcription.
Figure 5. Glucose and amino acids control rRNA transcription. Glucose, amino acids, and GTP control rRNA
transcription through several pathways, such as ERK, mTOR/S6K, and AMPK, which control PIC components (UBF,
SL1, and TIF-IA), transcription factors (c-Myc), or chromatin regulators (KDM2A, PIH1, and SIRT1/NML). High
glucose activates ERK and mTOR/S6K pathways to control UBF. High glucose also activates PIH1 to control chro-
matin. Glucose depletion or low energy conditions activate SIRT1/NML and the AMPK pathway. Activated AMPK
controls the activities of TIF-IA and KDM2A. Activated KDM2A controls rDNA chromatin to inhibit rRNA tran-
scription. Amino acid depletion represses the mTOR pathway, resulting in the repression of TIF-IA, and decreases the
expression of c-Myc. Guanosine triphosphate (GTP) is bound to TIF-IA, and the binding is required to control rRNA
transcription.
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics34
Ribosomal biogenesis including rRNA transcription was reported to be induced by high
glucose treatment or diabetes. A high level of glucose activates UBF through ERK1/2 and
mTOR in kidney glomerular epithelial cells of mice [74].
The PIH1 domain-containing protein 1 (PIH1)/Nop17 is reported to enhance rRNA transcrip-
tion through the recruitment of SNF5-Brg1 complex on the rRNA promoter [75] (Figure 5). The
complex increases acetylation of several histones, except histone H4K16Ac, on rDNA in high
glucose conditions. Until now, the acetylation marks of histone in rDNA, excluding the acety-
lation at K16 in histone H4 (H4K16Ac), are linked to activation of transcription. The acetylated
histones function as active marks in transcription in many cases because the acetylation of
histone weakens the interaction of histone octamers with DNA, and the acetylated histones are
recognized by several transcription-activating factors. On the other hand, the H4K16Ac mark
is reported to be recognized by nucleolar remodeling complex (NoRC) in rDNA, which
induces chromatin-silencing status [76]. Glucose starvation dissociates PIH1 and the SNF5-
Brg1 complex from rDNA and increases histone H4K16Ac marks, which repress rRNA tran-
scription [75]. Another report suggested that PIH1 interacts with mTORC1 to stabilize it,
resulting in enhancement of rRNA transcription [77].
8.4. AMPK is activated by glucose starvation
Glucose starvation decreases ATP production and activates AMPK (Figure 5). The AMP-
activated kinase (AMPK) is known as an energy sensor, which recognizes the ratios of AMP,
ADP, and ATP and regulates many phenomena in cells to maintain energy homeostasis.
Additionally, a recent study showed the existence of an AMP/ADP-independent mechanism
that triggers AMPK activation (Figure 6). Glycolysis is a determined sequence of 10 enzyme-
catalyzed reactions. In the fourth step, the hexose ring of fructose 1, 6-bisphosphate (FBP) is
split by aldolase into two triose sugars: dihydroxyacetone phosphate (a ketose) and glyceral-
dehyde 3-phosphate (an aldose). When extracellular glucose is decreased, intracellular FBP is
decreased, and aldolase unoccupied by FBP promotes the formation of a lysosomal complex
containing v-ATPase axin, liver kinase B1 (LKB1), and AMPK, which regulates AMPK activity
[78]. These results suggest that the decreased level of the metabolite in glycolysis controls
AMPK before the reduction of ATP production just after changing environmental conditions,
emphasizing that AMPK is a highly sensitive monitor of energy conditions.
AMPK induces phosphorylation of TIF-IA (Figure 5). The phosphorylation of TIF-IA by
AMPK reduces interaction of TIF-IA with SL1, decreases the TIF-IA amount on the rDNA
promoter, and interrupts PIC assembly, which results in the reduction of rRNA transcription
[79].
KDM2A, identified as mono- and di-methylated lysine 36 on histone H3 (H3K36me1/2)
demethylase [80], is accumulated in the nucleolus and binds to rDNA [81]. The repression of
rRNA transcription by KDM2A is induced in response to serum and glucose starvation
(Figure 5). The repression requires the demethylase activity of KDM2A on the rDNA promoter
[82]. The KDM2A-dependent regulation affects the levels of protein synthesis [81]. The
demethylase activity of KDM2A proceeds with a co-reaction in which α-ketoglutarate (α-KG)
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is converted to succinate, both of which are organic acids constituting the TCA cycle. Interest-
ingly, the enzyme activity of KDM2A is controlled by cell-permeable succinate (dimethyl
succinate: DMS), suggesting that metabolites in the TCA cycle affect KDM2A activity. Recently,
it was found that glucose starvation in the presence of serum induces the repression of rRNA
transcription by KDM2A, in which activated AMPK induces KDM2A activity [83] (Figure 5).
Interestingly, treatment with a low concentration of the glycolysis inhibitor 2-deoxy-D-glucose
(2DG) induces KDM2A-dependent repression of rRNA transcription associated with histone
demethylation on the rDNA promoter, although it does not dissociate TIF-IA from the rDNA
promoter. Treatment with a high concentration of 2DG induces both the dissociation of TIF-IA
from the rDNA promoter and KDM2A-dependent demethylation of the rDNA promoter.
These results suggest that the repression of rRNA transcription in response to glucose starva-
tion is performed by two different mechanisms: epigenetic regulation by KDM2A and TIF-IA
regulation, depending on the glucose starvation level.
AMPK phosphorylates dozens of proteins, but until now KDM2A has not been detected as a
substrate of AMPK kinase activity. AMPK also controls the activity of mTOR [84], and mTOR
Figure 6. Control of methylation by energy status and methyl marks as a reservoir for biological resources. Chromatin
components are methylated and demethylated by specific enzymes influenced by metabolites in energy production.
Formaldehyde is produced as a demethylation byproduct, directly generates one carbon unit, fuels the folate cycle
through alcohol dehydrogenase 5 (ADH5) activity, and can be used as a source for production of SAM, which is used for
methylation and nucleotides. AMPK, AMP-activated protein kinase; DHF, dihydrofolate; FBP, fructose 1, 6-bisphosphate;
3PG, 3-phosphoglycerate; SAM, S-adenosylmethionine; THF, tetrahydrofolate.
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is a candidate kinase for control of the states of histone methylation in the rDNA promoter, but
currently there is no evidence connecting mTOR and KDM2A. Further studies are required to
determine how the KDM2A activity in the rDNA promoter is induced by AMPK. H3K36me2
on the rDNA promoter which is demethylated by KDM2A on starvation is quickly restored by
refeeding glucose and serum [82]. The data suggest that the control of H3K36me2 levels on
rDNA promoters is reversible by changes in nutrient status, although which enzyme induces
methylation of H3K36me2 on the rDNA promoter in response to refeeding of glucose and
serum remains unknown. The control mechanism of rRNA transcription through epigenetic
regulation by KDM2A may be a fine tuning device that quickly reflects nutrient states around
cells.
8.5. Sirtuins
Sirtuins target a wide range of cellular proteins in the nucleus, cytoplasm, and mitochondria
for post-translational modification by acetylation (SirT1, 2, 3, and 5) or ADP-ribosylation (SirT4
and 6). The deacetylase activity of sirtuins is controlled by the cellular NAD+/NADH ratio,
where NAD+works as an activator, while nicotinamide and NADH act as inhibitors (Figure 7).
The acetylation regulates a wide variety of cellular functions. Sirtuins participate in various
cellular processes, deacetylating both chromatin and non-histone proteins, and their roles in
aging have been extensively studied. Sirtuins may also play a critical role in tumor initiation
and progression as well as drug resistance. Reduced compounds such as glucose and fatty
acids are oxidized, thereby releasing energy. This energy is transferred to NAD+ by reduction
to NADH, as part of glycolysis, the citric acid cycle, and β-oxidation. The mitochondrial
Figure 7. Control of acetylation by energy status and acetyl marks as a reservoir for biological resources. Chromatin
components are acetylated and deacetylated by specific enzymes whose activities are influenced by metabolites in energy
production. During deacetylation, the acetyl group from the substrate is accepted by the ribose to produce O-acetyl-ADP-
ribose (OAADPr). A cytoplasmic esterase, which was suggested to be ADP-ribosyl hydrolase 3 (ARH3), hydrolyzesOAADPr
to acetate and ADPr. Acetate that is generated from the deacetylation may be changed to acetyl-CoA, and used as resource
for acetyl marks and lipogenesis. ACECSI, acetyl-CoA synthase 1; ACL, ATP-citrate lyase; OAADPr, O-acetyl ADP-ribose.
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NADH is then oxidized in turn by the electron transport chain, which generates ATP through
oxidative phosphorylation.
SIRT1 was reported to be required for the recruitment of nucleomethylin (NML) on rDNA. In
response to glucose starvation, rRNA transcription is repressed through NML-induced chro-
matin regulation [85]. Although it is not clear that SIRT1 shows deacetylase activity on starva-
tion, SIRT1 induces the deacetylation of p53, and this deacetylation activity is required for the
repression of rRNA transcription. Further, the NAD+ synthesis enzyme nicotinamide mononu-
cleotide adenylyltransferase (NMNAT1) modulates the repression of rRNA transcription [86].
As described above, SIRT1 is required for mitotic repression of rRNA transcription through
deacetylation of TAFI68 (Figure 3 and section 3). TAFI68 is acetylated by PCAF to restart
transcription in the mitotic exit phase [18].
On the other hand, SIRT7, another SIRT family member, was reported to activate rRNA
transcription depending on the deacetylation activity, through regulation of PAF53, which is
an important component of Pol I complex [87–91].
8.6. Epigenetic marks may play a role in conserving biological resources
Acetyl-CoA is used as an acetyl group donor on acetylation of histone and other proteins
(Figure 7). Acetyl-CoA is produced from pyruvate, acetate, or fatty acid oxidation in multiple
metabolisms. The amount of acetyl-CoA affects the activity of histone acetyltransferases
(HATs). S-adenosylmethionine (SAM) is known to be used as a methyl donor in DNA/histone
(protein) methylation (Figure 6). SAM is produced through the condensation of methionine
and ATP by methionine adenosyltransferase (MAT). The production of SAM is mediated
through the folate and methionine cycles. The amount of SAM is thought to affect the activity
of methylase. The production of the two epigenetic marks is clearly affected by energy produc-
tion processes, suggesting that intracellular energy conditions affect the modifications of
epigenetic marks [92–94].
Further, enzymes detaching the marks are also affected by metabolites in energy production.
NAD+ activates sirtuin deacetylase, while nicotinamide andNADH inhibit the activity (Figure 7).
The demethylase activity of KDM2A is controlled by the amounts of intracellular ATP through
AMPK (Figure 6), and probably more directly by succinate. In another report, chromatin-
associated fumarase generating fumarate inhibits the demethylation activity of KDM2A on the
promoter region of the RNA polymerase II gene [95]. Additionally, 2-hydroxy-glutarate (2-HG),
which was produced from α-KG by a mutant type isocitrate dehydrogenase (IDH) also modu-
lates several jmjC-type enzymes including the lysine-specific demethylases (KDMs) such as
KDM2A and Tet methyl-cytosine dioxygenases (TETs) [96–98]. Therefore, metabolites reflecting
intracellular energy conditions can control the enzymes for detaching the epigenetic marks as
well as adding them.
Interestingly, during deacetylation, the glycosidic bond of the nicotinamide ribose is cleaved to
yield nicotinamide, and the ribose accepts the acetyl group from the substrate to produce
O-acetyl-ADP-ribose (OAADPr). In vitro, a cytoplasmic esterase from humans and yeast,
which was suggested to be ADP-ribosyl hydrolase 3, hydrolyzes OAADPr to acetate and
ADPr [99]. Therefore, acetyl marks of proteins that are deacetylated by sirtuin may also be
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used as a source of acetate for acetyl marks and lipogenesis (Figure 7). KDMs catalyze histone
lysine demethylation through an oxidative reaction. The catalytic reaction begins with the
coordination of molecular oxygen (O2) by Fe(II) and the conversion of α-KG to succinate and
CO2 with the concomitant hydroxylation of the methyl group of the peptide substrate. The
resulting carbinolamine is unstable and degrades spontaneously to an unmethylated peptide
and the cytotoxic molecule formaldehyde (Figure 6). Recently, it was shown that formalde-
hyde reacts spontaneously with glutathione (GSH) to yield S-hydroxymethylglutathione
(HMGSH), and subsequently HMGSH is oxidized by alcohol dehydrogenase 5 with NAD
(P)+ to create S-formylglutathione. This biochemical route provides a cell with formaldehyde
detoxification as well as utilizable one-carbon units, which contribute to nucleotide synthesis.
Therefore, cells reserve materials for one-carbon metabolism as methyl marks [100], which are
released by KDM2A on starvation. These two examples of acetylation and methylation suggest
that modifications of the epigenetic marks are not only controlled by intracellular energy
conditions, but also function as reservoirs in chromatin for biological resources.
9. Applications for therapy
Enlarged nucleoli have been recognized as a hallmark of cancer cells [101, 102]. Elevated levels
of rRNA transcription and protein synthesis are often observed in cancer cells. These observations
suggest the possibility that the control of rRNA transcription could regulate the proliferation of
cancer cells. Actually, the anti-cancer effects of some compounds are associated with down-
regulation of rRNA transcription. Cisplatin [103], mitomycin C [104], and 5-fluorouracil [105],
well-known anti-cancer drugs, are reported to inhibit rRNA transcription [11]. However, it is
not clear whether the reduction of rRNA transcription in cancer cells is causal or only as a
consequence of inhibition of cell growth.
On the other hand, there are drugs that appear to reduce rRNA transcription and then repress
cancer growth. Actinomycin D (Dactinomycin) specifically represses rRNA synthesis at low
concentrations through inactivation of transcriptional elongation by Pol I by interaction with
GC-rich regions of rDNA, and thus inhibits growth of cancer cells. Actinomycin D is used as a
chemotherapy medication to treat a number of types of cancer, including gestational tropho-
blastic neoplasia [106], Wilms tumor [107], rhabdomyosarcoma [108], Ewing’s sarcoma [109],
and malignant hydatidiform mole [110].
CX-5461 was identified by screening for selective inhibitors of Pol I but not Pol II transcription.
CX-5461 specifically inhibits ribosomal RNA transcription by impairment of SL1 binding to
the rDNA promoter [111] and thus exhibits anti-cancer activity [83, 111]. The inhibition of
rRNA synthesis by CX-5461 leads to senescence and autophagy in a p53-independent manner
in a tumor cell line [111], to activation of p53-dependent apoptotic signaling in Myc-
overexpressing B-lymphoma cells (Eμ-Myc lymphoma cells) [112], and to activation of the
ATM/Ataxia Telangiectasia and Rad3-related protein (ATR) pathway in acute lymphoblastic
leukemia to induce G2 arrest and apoptosis [113]. The potential therapeutic effect of CX-5461
was demonstrated in xenograft models using human pancreatic carcinoma (MIA PaCa-2),
melanoma (A375) [111], biphenotypic B myelomonocytic leukemia (MV 4;11) [112] and breast
cancer susceptibility gene II (BRCA2) deficient colon cancer (HCT116) [114], and in mice
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models transplanted with p53 wild-type Eμ-Myc lymphoma [112]. The treatment of CX-5461
in these experiments hardly affected on the health and body weights of mice [111, 112].
BMH-21, which was identified by cell-based screening, intercalates into GC-rich sequences,
which exist at a high frequency in rDNA, and represses Pol I transcription [115]. Treatment
with BMH-21 induces proteasome-dependent degradation of the largest catalytic subunit of
Pol I, RPA194, resulting in a decrease of the Pol I level on rDNA. These effects were correlated
to the anti-cancer activity of BHM-21. The anti-tumor activity of BMH-21 was demonstrated
using human melanoma (A375) and colorectal carcinoma (HCT116) xenograft models with
little effect on body weight [115]. These studies suggest that the chemicals that repress the
rRNA transcription show anti-cancer activities.
Epigenetic controls of rDNA chromatin are also candidates for cancer therapy. For example,
specific activation of KDM2A could reduce cancer cell proliferation. Because KDM2A activity
is regulated by ATP levels through AMPK and also metabolites in energy production, control
of these compound levels may regulate KDM2A activity and cell proliferation. As seen here,
there are many elaborate mechanisms for control of rRNA transcription, some of which
involve intracellular metabolites, which are produced from environmental nutriments. Further
studies of the relationship between rRNA transcription and nutrients will provide information
about the mechanisms by which cells reconcile demand and usage of biological resources, and
clues for novel methods to treat cancers.
10. Conclusion
The construction of ribosomes consumes the majority of the cell’s materials and energy. Because
the materials for ribosome production are supplied by nutrients, the production of ribosomes is
largely restricted by environmental nutrients and cells need mechanisms to control ribosome
production in order to reconcile demands for cell activities with available resources. Transcrip-
tion of rRNA is an essential step in ribosome biogenesis, and strongly affects the total amount of
ribosome production. Ribosomal RNA transcription is controlled by many mechanisms, includ-
ing the efficiency of PIC formation for Pol I and epigenetic marks in rDNA. These are affected by
nutrients. Recent studies suggest that the epigenetic marks, such as acetylation and methylation,
may be not only controlled by nutrients but also function as reservoirs for biological resources in
chromatin. Elevated levels of rRNA transcription and protein synthesis are often observed in
cancer cells, and the control of rRNA transcription can regulate their proliferation. Indeed some
chemicals that repress the rRNA transcription show anti-cancer activities. Further studies of the
relationship between rRNA transcription and nutrients will provide clues for novel methods to
treat cancers.
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TAFIs TBP-associated factors for RNA polymerase I
TBP TATA-box binding protein
TIF-IA Transcription initiation factor IA
UBF Upstream binding factor
Author details
Yuji Tanaka and Makoto Tsuneoka*
*Address all correspondence to: tsuneoka@takasaki-u.ac.jp
Faculty of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Japan
References
[1] Khatter H, Myasnikov AG, Natchiar SK, Klaholz BP. Structure of the human 80S ribo-
some. Nature. 2015;520(7549):640-645. DOI: 10.1038/nature14427
[2] Melnikov S, Ben-Shem A, Garreau de Loubresse N, Jenner L, Yusupova G, Yusupov M.
One core, two shells: Bacterial and eukaryotic ribosomes. Nature Structural & Molecular
Biology. 2012;19(6):560-567. DOI: 10.1038/nsmb.2313
[3] Schmidt EV. The role of c-myc in regulation of translation initiation. Oncogene.
2004;23(18):3217-3221. DOI: 10.1038/sj.onc.1207548
[4] Kusnadi EP, Hannan KM, Hicks RJ, Hannan RD, Pearson RB, Kang J. Regulation of rDNA
transcription in response to growth factors, nutrients and energy. Gene. 2015;556(1):27-34.
DOI: 10.1016/j.gene.2014.11.010
[5] Thomas G. An encore for ribosome biogenesis in the control of cell proliferation. Nature
Cell Biology. 2000;2(5):E71-E72. DOI: 10.1038/35010581
[6] Olson MOJ. The Nucleolus. Vol. xxv. New York: Springer; 2011. p. 414, DOI: absent
[7] Grummt I. Different epigenetic layers engage in complex crosstalk to define the epige-
netic state of mammalian rRNA genes. Human Molecular Genetics. 2007;16(Spec No 1):
R21-R27. DOI: 10.1093/hmg/ddm020
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics42
[8] Grummt I. Life on a planet of its own: Regulation of RNA polymerase I transcription in
the nucleolus. Genes & Development. 2003;17(14):1691-1702. DOI: 10.1101/gad.1098503R
[9] Grummt I. Wisely chosen paths – regulation of rRNA synthesis: Delivered on 30 June
2010 at the 35th FEBS Congress in Gothenburg, Sweden. The FEBS Journal. 2010;277(22):
4626-4639. DOI: 10.1111/j.1742-4658.2010.07892.x
[10] Jackson DA, Pombo A, Iborra F. The balance sheet for transcription: An analysis of
nuclear RNA metabolism in mammalian cells. The FASEB Journal 2000;14(2):242-254.
DOI: absent
[11] Drygin D, Rice WG, Grummt I. The RNA polymerase I transcription machinery: An
emerging target for the treatment of cancer. Annual Review of Pharmacology and
Toxicology. 2010;50:131-156. DOI: 10.1146/annurev.pharmtox.010909.105844
[12] Zomerdijk JC, Beckmann H, Comai L, Tjian R. Assembly of transcriptionally active RNA
polymerase I initiation factor SL1 from recombinant subunits. Science 1994;266(5193):
2015-2018. DOI: absent
[13] Goodfellow SJ, Zomerdijk JC. Basic mechanisms in RNA polymerase I transcription of
the ribosomal RNA genes. Sub-Cellular Biochemistry. 2013;61:211-236. DOI: 10.1007/
978-94-007-4525-4_10
[14] Loyer P, Trembley JH, Katona R, Kidd VJ, Lahti JM. Role of CDK/cyclin complexes in
transcription and RNA splicing. Cellular Signalling. 2005;17(9):1033-1051. DOI: 10.1016/
j.cellsig.2005.02.005
[15] Lim S, Kaldis P. Cdks, cyclins and CKIs: Roles beyond cell cycle regulation. Development.
2013;140(15):3079-3093. DOI: 10.1242/dev.091744
[16] Heix J, Vente A, Voit R, Budde A, Michaelidis TM, Grummt I. Mitotic silencing of human
rRNA synthesis: Inactivation of the promoter selectivity factor SL1 by cdc2/cyclin
B-mediated phosphorylation. The EMBO Journal. 1998;17(24):7373-7381. DOI: 10.1093/
emboj/17.24.7373
[17] Kuhn A, Vente A, Doree M, Grummt I. Mitotic phosphorylation of the TBP-containing
factor SL1 represses ribosomal gene transcription. Journal of Molecular Biology. 1998;
284(1):1-5. DOI: 10.1006/jmbi.1998.2164
[18] Voit R, Seiler J, Grummt I. Cooperative action of Cdk1/cyclin B and SIRT1 is required for
mitotic repression of rRNA synthesis. PLoS Genetics. 2015;11(5):e1005246. DOI: 10.1371/
journal.pgen.1005246
[19] Voit R, Hoffmann M, Grummt I. Phosphorylation by G1-specific cdk-cyclin complexes
activates the nucleolar transcription factor UBF. The EMBO Journal. 1999;18(7):1891-
1899. DOI: 10.1093/emboj/18.7.1891
[20] Voit R, Grummt I. Phosphorylation of UBF at serine 388 is required for interaction with
RNA polymerase I and activation of rDNA transcription. Proceedings of the National
Control of Ribosomal RNA Transcription by Nutrients
http://dx.doi.org/10.5772/intechopen.71866
43
Academy of Sciences of the United States of America. 2001;98(24):13631-13636. DOI:
10.1073/pnas.231071698
[21] Voit R, Schnapp A, Kuhn A, Rosenbauer H, Hirschmann P, Stunnenberg HG, et al. The
nucleolar transcription factor mUBF is phosphorylated by casein kinase II in the
C-terminal hyperacidic tail which is essential for transactivation. The EMBO Journal
1992;11(6):2211-2218. DOI: absent
[22] Kihm AJ, Hershey JC, Haystead TA, Madsen CS, Owens GK. Phosphorylation of the
rRNA transcription factor upstream binding factor promotes its association with TATA
binding protein. Proceedings of the National Academy of Sciences of the United States
of America 1998;95(25):14816-14820. DOI: absent
[23] Lin CY, Navarro S, Reddy S, Comai L. CK2-mediated stimulation of Pol I transcription
by stabilization of UBF-SL1 interaction. Nucleic Acids Research. 2006;34(17):4752-4766.
DOI: 10.1093/nar/gkl581
[24] Panova TB, Panov KI, Russell J, Zomerdijk JC. Casein kinase 2 associates with initiation-
competent RNA polymerase I and has multiple roles in ribosomal DNA transcription.
Molecular and Cellular Biology. 2006;26(16):5957-5968. DOI: 10.1128/MCB.00673-06
[25] Bierhoff H, Dundr M, Michels AA, Grummt I. Phosphorylation by casein kinase 2
facilitates rRNA gene transcription by promoting dissociation of TIF-IA from elongating
RNA polymerase I. Molecular and Cellular Biology. 2008;28(16):4988-4998. DOI: 10.1128/
MCB.00492-08
[26] Nguyen le XT, Mitchell BS. Akt activation enhances ribosomal RNA synthesis through
casein kinase II and TIF-IA. Proceedings of the National Academy of Sciences of the
United States of America. 2013;110(51):20681-20686. DOI: 10.1073/pnas.1313097110
[27] Mayer C, Zhao J, Yuan X, Grummt I. mTOR-dependent activation of the transcription
factor TIF-IA links rRNA synthesis to nutrient availability. Genes & Development.
2004;18(4):423-434. DOI: 10.1101/gad.285504
[28] Hannan KM, Brandenburger Y, Jenkins A, Sharkey K, Cavanaugh A, Rothblum L, et al.
mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is medi-
ated by phosphorylation of the carboxy-terminal activation domain of the nucleolar tran-
scription factor UBF. Molecular and Cellular Biology 2003;23(23):8862-8877. DOI: absent
[29] Lee D, An J, Park YU, Liaw H, Woodgate R, Park JH, et al. SHPRH regulates rRNA
transcription by recognizing the histone code in an mTOR-dependent manner. Proceed-
ings of the National Academy of Sciences of the United States of America. 2017;114(17):
E3424-E3433. DOI: 10.1073/pnas.1701978114
[30] Salifou K, Ray S, Verrier L, Aguirrebengoa M, Trouche D, Panov KI, et al. The histone
demethylase JMJD2A/KDM4A links ribosomal RNA transcription to nutrients and growth
factors availability. Nature Communications. 2016;7:10174. DOI: 10.1038/ncomms10174
[31] Liu L, Pilch PF. PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in
response to metabolic challenges. eLife. 2016;5:e17508. DOI: 10.7554/eLife.17508
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics44
[32] Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI, Moss T. An
immediate response of ribosomal transcription to growth factor stimulation in mam-
mals is mediated by ERK phosphorylation of UBF. Molecular Cell. 2001;8(5):1063-1073.
DOI: S1097-2765(01)00384-7
[33] Stefanovsky V, Langlois F, Gagnon-Kugler T, Rothblum LI, Moss T. Growth factor
signaling regulates elongation of RNA polymerase I transcription in mammals via UBF
phosphorylation and r-chromatin remodeling. Molecular Cell. 2006;21(5):629-639. DOI:
10.1016/j.molcel.2006.01.023
[34] Zhao J, Yuan X, Frodin M, Grummt I. ERK-dependent phosphorylation of the transcrip-
tion initiation factor TIF-IA is required for RNA polymerase I transcription and cell
growth. Molecular Cell. 2003;11(2):405-413. DOI: S1097-2765(03)00036-4
[35] Tsoi H, Lam KC, Dong Y, Zhang X, Lee CK, Zhang J, et al. Pre-45s rRNA promotes colon
cancer and is associated with poor survival of CRC patients. Oncogene. 2017;36:6109-
6118. DOI: 10.1038/onc.2017.86
[36] Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, et al. c-Myc associates with
ribosomal DNA and activates RNA polymerase I transcription. Nature Cell Biology.
2005;7(3):303-310. DOI: 10.1038/ncb1225
[37] Frescas D, Guardavaccaro D, Bassermann F, Koyama-Nasu R, Pagano M. JHDM1B/
FBXL10 is a nucleolar protein that represses transcription of ribosomal RNA genes.
Nature. 2007;450(7167):309-313. DOI: 10.1038/nature06255
[38] Bierhoff H, Dammert MA, Brocks D, Dambacher S, Schotta G, Grummt I. Quiescence-
induced LncRNAs trigger H4K20 trimethylation and transcriptional silencing. Molecu-
lar Cell. 2014;54(4):675-682. DOI: 10.1016/j.molcel.2014.03.032
[39] Xie W, Ling T, Zhou Y, FengW, Zhu Q, Stunnenberg HG, et al. The chromatin remodeling
complex NuRD establishes the poised state of rRNA genes characterized by bivalent
histonemodifications and altered nucleosome positions. Proceedings of the National Acad-
emy of Sciences of the United States of America. 2012;109(21):8161-8166. DOI: 10.1073/
pnas.1201262109
[40] Grandori C, Gomez-Roman N, Felton-Edkins ZA, Ngouenet C, Galloway DA, Eisenman
RN, et al. c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA
genes by RNA polymerase I. Nature Cell Biology. 2005;7(3):311-318. DOI: 10.1038/ncb1224
[41] Poortinga G, Hannan KM, Snelling H, Walkley CR, Jenkins A, Sharkey K, et al. MAD1
and c-MYC regulate UBF and rDNA transcription during granulocyte differentiation.
The EMBO Journal. 2004;23(16):3325-3335. DOI: 10.1038/sj.emboj.7600335
[42] Dai MS, Lu H. Crosstalk between c-Myc and ribosome in ribosomal biogenesis and
cancer. Journal of Cellular Biochemistry. 2008;105(3):670-677. DOI: 10.1002/jcb.21895
[43] Poortinga G, Wall M, Sanij E, Siwicki K, Ellul J, Brown D, et al. c-MYC coordinately
regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte
differentiation. Nucleic Acids Research. 2011;39(8):3267-3281. DOI: 10.1093/nar/gkq1205
Control of Ribosomal RNA Transcription by Nutrients
http://dx.doi.org/10.5772/intechopen.71866
45
[44] Schmidt EV. The role of c-myc in cellular growth control. Oncogene. 1999;18(19):2988-
2996. DOI: 10.1038/sj.onc.1202751
[45] van Riggelen J, Yetil A, Felsher DW. MYC as a regulator of ribosome biogenesis and
protein synthesis. Nature Reviews. Cancer 2010;10(4):301-309. DOI: 10.1038/nrc2819
[46] Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI. Activity
of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature.
1995;374(6518):177-180. DOI: 10.1038/374177a0
[47] Voit R, Schafer K, Grummt I. Mechanism of repression of RNA polymerase I transcrip-
tion by the retinoblastoma protein. Molecular and Cellular Biology 1997;17(8):4230-4237.
DOI: absent
[48] Hannan KM, Hannan RD, Smith SD, Jefferson LS, Lun M, Rothblum LI. Rb and p130
regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and
SL-1. Oncogene. 2000;19(43):4988-4999. DOI: 10.1038/sj.onc.1203875
[49] Pelletier G, Stefanovsky VY, Faubladier M, Hirschler-Laszkiewicz I, Savard J, Rothblum
LI, et al. Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and
ribosomal transcription. Molecular Cell. 2000;6(5):1059-1066. DOI: S1097-2765(00)00104-0
[50] Zhai W, Comai L. Repression of RNA polymerase I transcription by the tumor suppres-
sor p53. Molecular and Cellular Biology 2000;20(16):5930-5938. DOI: absent
[51] Zhang C, Comai L, Johnson DL. PTEN represses RNA polymerase I transcription by
disrupting the SL1 complex. Molecular and Cellular Biology. 2005;25(16):6899-6911.
DOI: 10.1128/MCB.25.16.6899-6911.2005
[52] Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T. Cooperative phosphorylation of
the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and
glycogen synthase kinase 3beta. The Journal of Biological Chemistry. 2005;280(42):
35195-35202. DOI: 10.1074/jbc.M503045200
[53] Vincent T, Kukalev A, Andang M, Pettersson R, Percipalle P. The glycogen synthase
kinase (GSK) 3beta represses RNA polymerase I transcription. Oncogene. 2008;27(39):
5254-5259. DOI: 10.1038/onc.2008.152
[54] Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: Regulation, func-
tion and role in human disease. Biochimica et Biophysica Acta. 2007;1773(8):1341-1348.
DOI: 10.1016/j.bbamcr.2006.12.009
[55] Mayer C, Bierhoff H, Grummt I. The nucleolus as a stress sensor: JNK2 inactivates the
transcription factor TIF-IA and down-regulates rRNA synthesis. Genes & Development.
2005;19(8):933-941. DOI: 10.1101/gad.333205
[56] Larsen DH, Hari F, Clapperton JA, Gwerder M, Gutsche K, Altmeyer M, et al. The
NBS1-treacle complex controls ribosomal RNA transcription in response to DNA dam-
age. Nature Cell Biology. 2014;16(8):792-803. DOI: 10.1038/ncb3007
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics46
[57] Kruhlak M, Crouch EE, Orlov M, Montano C, Gorski SA, Nussenzweig A, et al. The
ATM repair pathway inhibits RNA polymerase I transcription in response to chromo-
some breaks. Nature. 2007;447(7145):730-734. DOI: 10.1038/nature05842
[58] Johnston R, D'Costa Z, Ray S, Gorski J, Harkin DP, Mullan P, et al. The identification
of a novel role for BRCA1 in regulating RNA polymerase I transcription. Oncotarget.
2016;7(42):68097-68110. DOI: 10.18632/oncotarget.11770
[59] Zhao Z, Dammert MA, Hoppe S, Bierhoff H, Grummt I. Heat shock represses rRNA
synthesis by inactivation of TIF-IA and lncRNA-dependent changes in nucleosome
positioning. Nucleic Acids Research. 2016;44(17):8144-8152. DOI: 10.1093/nar/gkw496
[60] Zhao Z, Dammert MA, Grummt I, Bierhoff H. lncRNA-induced nucleosome repositioning
reinforces transcriptional repression of rRNA genes upon hypotonic stress. Cell Reports.
2016;14(8):1876-1882. DOI: 10.1016/j.celrep.2016.01.073
[61] Wu TH, Kuo YY, Lee HH, Kuo JC, Ou MH, Chang ZF. Epigenetic repression of ribo-
somal RNA transcription by ROCK-dependent aberrant cytoskeletal organization. Sci-
entific Reports. 2016;6:28685. DOI: 10.1038/srep28685
[62] Moor AE, Golan M, Massasa EE, Lemze D, Weizman T, Shenhav R, et al. Global mRNA
polarization regulates translation efficiency in the intestinal epithelium. Science.
2017;357(6357):1299-1303. DOI: 10.1126/science.aan2399
[63] Ma XM, Blenis J. Molecular mechanisms of mTOR-mediated translational control.
Nature Reviews. Molecular Cell Biology. 2009;10(5):307-318. DOI: 10.1038/nrm2672
[64] Gonzalez A, Hall MN. Nutrient sensing and TOR signaling in yeast and mammals. The
EMBO Journal. 2017;36(4):397-408. DOI: 10.15252/embj.201696010
[65] Grummt I, Smith VA, Grummt F. Amino acid starvation affects the initiation frequency
of nucleolar RNA polymerase. Cell. 1976;7(3):439-445. DOI: 0092-8674(76)90174-4
[66] Yuan X, Zhao J, Zentgraf H, Hoffmann-Rohrer U, Grummt I. Multiple interactions
between RNA polymerase I, TIF-IA and TAF(I) subunits regulate preinitiation complex
assembly at the ribosomal gene promoter. EMBO Reports. 2002;3(11):1082-1087. DOI:
10.1093/embo-reports/kvf212
[67] James MJ, Zomerdijk JC. Phosphatidylinositol 3-kinase and mTOR signaling pathways
regulate RNA polymerase I transcription in response to IGF-1 and nutrients. The Journal
of Biological Chemistry. 2004;279(10):8911-8918. DOI: 10.1074/jbc.M307735200
[68] West MJ, Stoneley M, Willis AE. Translational induction of the c-myc oncogene via
activation of the FRAP/TOR signalling pathway. Oncogene. 1998;17(6):769-780. DOI:
10.1038/sj.onc.1201990
[69] Csibi A, Lee G, Yoon SO, Tong H, Ilter D, Elia I, et al. The mTORC1/S6K1 pathway
regulates glutamine metabolism through the eIF4B-dependent control of c-Myc transla-
tion. Current Biology. 2014;24(19):2274-2280. DOI: 10.1016/j.cub.2014.08.007
Control of Ribosomal RNA Transcription by Nutrients
http://dx.doi.org/10.5772/intechopen.71866
47
[70] Kang J, Kusnadi EP, Ogden AJ, Hicks RJ, Bammert L, Kutay U, et al. Amino acid-
dependent signaling via S6K1 and MYC is essential for regulation of rDNA transcrip-
tion. Oncotarget. 2016;7(31):48887-48904. DOI: 10.18632/oncotarget.10346
[71] Grummt I, Grummt F. Control of nucleolar RNA synthesis by the intracellular pool sizes
of ATP and GTP. Cell. 1976;7(3):447-453. DOI: 0092-8674(76)90175-6
[72] Nguyen le XT, Lee Y, Urbani L, Utz PJ, Hamburger AW, Sunwoo JB, et al. Regu-
lation of ribosomal RNA synthesis in T cells: Requirement for GTP and Ebp1.
Blood. 2015;125(16):2519-2529. DOI: 10.1182/blood-2014-12-616433
[73] Squatrito M, Mancino M, Donzelli M, Areces LB, Draetta GF. EBP1 is a nucleolar
growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.
Oncogene. 2004;23(25):4454-4465. DOI: 10.1038/sj.onc.1207579
[74] Mariappan MM, D'Silva K, Lee MJ, Sataranatarajan K, Barnes JL, Choudhury GG, et al.
Ribosomal biogenesis induction by high glucose requires activation of upstream binding
factor in kidney glomerular epithelial cells. American Journal of Physiology. Renal
Physiology. 2011;300(1):F219-F230. DOI: 10.1152/ajprenal.00207.2010
[75] Zhai N, Zhao ZL, Cheng MB, Di YW, Yan HX, Cao CY, et al. Human PIH1 associates
with histone H4 to mediate the glucose-dependent enhancement of pre-rRNA synthesis.
Journal of Molecular Cell Biology. 2012;4(4):231-241. DOI: 10.1093/jmcb/mjs003
[76] Zhou Y, Grummt I. The PHD finger/bromodomain of NoRC interacts with acetylated
histone H4K16 and is sufficient for rDNA silencing. Current Biology. 2005;15(15):1434-
1438. DOI: 10.1016/j.cub.2005.06.057
[77] Kamano Y, Saeki M, Egusa H, Kakihara Y, Houry WA, Yatani H, et al. PIH1D1 interacts
with mTOR complex 1 and enhances ribosome RNA transcription. FEBS Letters.
2013;587(20):3303-3308. DOI: 10.1016/j.febslet.2013.09.001
[78] Zhang CS, Hawley SA, Zong Y, Li M, Wang Z, Gray A, et al. Fructose-1,6-bisphosphate
and alDOIase mediate glucose sensing by AMPK. Nature. 2017;548(7665):112-116. DOI:
10.1038/nature23275
[79] Hoppe S, Bierhoff H, Cado I, Weber A, Tiebe M, Grummt I, et al. AMP-activated protein
kinase adapts rRNA synthesis to cellular energy supply. Proceedings of the National
Academy of Sciences of the United States of America. 2009;106(42):17781-17786. DOI:
10.1073/pnas.0909873106
[80] Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, et al.
Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006;
439(7078):811-816. DOI: 10.1038/nature04433
[81] Tanaka Y, Okamoto K, Teye K, Umata T, Yamagiwa N, Suto Y, et al. JmjC enzyme KDM2A
is a regulator of rRNA transcription in response to starvation. The EMBO Journal. 2010;29(9):
1510-1522. DOI: 10.1038/emboj.2010.56
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics48
[82] Tanaka Y, Umata T, Okamoto K, Obuse C, Tsuneoka M. CxxC-ZF domain is needed for
KDM2A to demethylate histone in rDNA promoter in response to starvation. Cell Struc-
ture and Function. 2014;39(1):79-92. DOI: 10.1247/csf.13022
[83] Tanaka Y, Yano H, Ogasawara S, Yoshioka S, Imamura H, Okamoto K, et al. Mild glucose
starvation induces KDM2A-mediatedH3K36me2Demethylation throughAMPK to reduce
rRNA transcription and cell proliferation. Molecular and Cellular Biology. 2015;35(24):
4170-4184. DOI: 10.1128/MCB.00579-15
[84] Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy response to control cell growth
and survival. Cell. 2003;115(5):577-590. DOI: 10.1016/S0092-8674(03)00929-2
[85] Yang L, Song T, Chen L, Kabra N, Zheng H, Koomen J, et al. Regulation of SirT1-
nucleomethylin binding by rRNA coordinates ribosome biogenesis with nutrient avail-
ability. Molecular and Cellular Biology. 2013;33(19):3835-3848. DOI: 10.1128/
MCB.00476-13
[86] Song T, Yang L, Kabra N, Chen L, Koomen J, Haura EB, et al. The NAD+ synthesis
enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT1) regulates ribo-
somal RNA transcription. The Journal of Biological Chemistry. 2013;288(29):20908-20917.
DOI: 10.1074/jbc.M113.470302
[87] Chen S, Seiler J, Santiago-Reichelt M, Felbel K, Grummt I, Voit R. Repression of RNA
polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of
PAF53 by SIRT7. Molecular Cell. 2013;52(3):303-313. DOI: 10.1016/j.molcel.2013.10.010
[88] Ford E, Voit R, Liszt G, Magin C, Grummt I, Guarente L. Mammalian Sir2 homolog SIRT7
is an activator of RNA polymerase I transcription. Genes & Development. 2006;20(9):1075-
1080. DOI: 10.1101/gad.1399706
[89] Hanada K, Song CZ, Yamamoto K, Yano K, Maeda Y, Yamaguchi K, et al. RNA poly-
merase I associated factor 53 binds to the nucleolar transcription factor UBF and func-
tions in specific rDNA transcription. The EMBO Journal 1996;15(9):2217-2226. DOI:
absent
[90] Meraner J, Lechner M, Loidl A, Goralik-Schramel M, Voit R, Grummt I, et al. Acetylation
of UBF changes during the cell cycle and regulates the interaction of UBF with RNA
polymerase I. Nucleic Acids Research. 2006;34(6):1798-1806. DOI: 10.1093/nar/gkl101
[91] Rothblum LI, Rothblum K, Chang E. PAF53 is essential in mammalian cells: CRISPR/
Cas9 fails to eliminate PAF53 expression. Gene. 2017;612:55-60. DOI: 10.1016/j.gene.
2016.12.023
[92] Wong CC, Qian Y, Yu J. Interplay between epigenetics and metabolism in oncogenesis:
Mechanisms and therapeutic approaches. Oncogene. 2017;36(24):3359-3374. DOI: 10.1038/
onc.2016.485
[93] Kaelin WG, Jr., McKnight SL. Influence of metabolism on epigenetics and disease. Cell
2013;153(1):56-69. DOI: 10.1016/j.cell.2013.03.004
Control of Ribosomal RNA Transcription by Nutrients
http://dx.doi.org/10.5772/intechopen.71866
49
[94] Krautkramer KA, Rey FE, Denu JM. Chemical signaling between gut microbiota and
host chromatin: What is your gut really saying? The Journal of Biological Chemistry.
2017;292(21):8582-8593. DOI: 10.1074/jbc.R116.761577
[95] Wang T, Yu Q, Li J, Hu B, Zhao Q, Ma C, et al. O-GlcNAcylation of fumarase maintains
tumour growth under glucose deficiency. Nature Cell Biology. 2017;19(7):833-843. DOI:
10.1038/ncb3562
[96] Losman JA, Kaelin WG, Jr. What a difference a hydroxyl makes: Mutant IDH, (R)-2-
hydroxyglutarate, and cancer. Genes & Development 2013;27(8):836-852. DOI: 10.1101/
gad.217406.113
[97] Chowdhury R, Yeoh KK, Tian YM, Hillringhaus L, Bagg EA, Rose NR, et al. The onco-
metabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Reports.
2011;12(5):463-469. DOI: 10.1038/embor.2011.43
[98] Xu W, Yang H, Liu Y, Yang Y, Wang P, Kim SH, et al. Oncometabolite 2-hydroxygluta
rate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer
Cell. 2011;19(1):17-30. DOI: 10.1016/j.ccr.2010.12.014
[99] Tong L, Denu JM. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose.
Biochimica et Biophysica Acta. 2010;1804(8):1617-1625. DOI: 10.1016/j.bbapap.2010.02.007
[100] Burgos-Barragan G, Wit N, Meiser J, Dingler FA, Pietzke M, Mulderrig L, et al. Mam-
mals divert endogenous genotoxic formaldehyde into one-carbon metabolism. Nature.
2017;548(7669):549-554. DOI: 10.1038/nature23481
[101] Ruggero D. Revisiting the nucleolus: From marker to dynamic integrator of cancer
signaling. Science Signaling. 2012;5(241):pe38. DOI: 10.1126/scisignal.2003477
[102] Quin JE, Devlin JR, Cameron D, Hannan KM, Pearson RB, Hannan RD. Targeting the
nucleolus for cancer intervention. Biochimica et Biophysica Acta. 2014;1842(6):802-816.
DOI: 10.1016/j.bbadis.2013.12.009
[103] Jordan P, Carmo-Fonseca M. Cisplatin inhibits synthesis of ribosomal RNA in vivo.
Nucleic Acids Research. 1998;26(12):2831-2836. DOI: gkb492
[104] Rey JP, Scott R, Muller H. Induction and removal of interstrand crosslinks in the ribo-
somal RNA genes of lymphoblastoid cell lines from patients with Fanconi anemia.
Mutation Research. 1993;289(2):171-180. DOI: 0027-5107(93)90067-P
[105] Ghoshal K, Jacob ST. An alternative molecular mechanism of action of 5-fluorouracil, a
potent anticancer drug. Biochemical Pharmacology. 1997;53(11):1569-1575. DOI: S0006-
2952(97)00040-3
[106] Turan T, Karacay O, Tulunay G, Boran N, Koc S, Bozok S, et al. Results with EMA/CO
(etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) chemotherapy
in gestational trophoblastic neoplasia. International Journal of Gynecological Cancer.
2006;16(3):1432-1438. DOI: 10.1111/j.1525-1438.2006.00606.x
Gene Expression and Regulation in Mammalian Cells - Transcription Toward the Establishment of Novel Therapeutics50
[107] D'Angio GJ, Evans A, BreslowN, Beckwith B, Bishop H, Farewell V, et al. The treatment of
Wilms' tumor: Results of the secondNational Wilms' tumor study. Cancer 1981;47(9):2302-
2311. DOI: absent
[108] Khatua S, Nair CN, Ghosh K. Immune-mediated thrombocytopenia following dacti-
nomycin therapy in a child with alveolar rhabdomyosarcoma: The unresolved issues.
Journal of Pediatric Hematology/Oncology. 2004;26(11):777-779. DOI: 00043426-2004
11000-00020
[109] Jaffe N, Paed D, Traggis D, Salian S, Cassady JR. Improved outlook for Ewing's sarcoma
with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide)
and radiation therapy. Cancer 1976;38(5):1925-1930. DOI: absent
[110] Uberti EM, Fajardo Mdo C, Ferreira SV, Pereira MV, Seger RC, Moreira MA, et al. Repro-
ductive outcome after discharge of patients with high-risk hydatidiform mole with or
without use of one bolus dose of actinomycin D, as prophylactic chemotherapy, during
the uterine evacuation of molar pregnancy. Gynecologic Oncology. 2009;115(3):476 481.
DOI: 10.1016/j.ygyno.2009.09.012
[111] Drygin D, Lin A, Bliesath J, Ho CB, O'Brien SE, Proffitt C, et al. Targeting RNA poly-
merase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and
solid tumor growth. Cancer Research. 2011;71(4):1418-1430. DOI: 10.1158/0008-5472.
CAN-10-1728
[112] Bywater MJ, Poortinga G, Sanij E, Hein N, Peck A, Cullinane C, et al. Inhibition of RNA
polymerase I as a therapeutic strategy to promote cancer-specific activation of p53.
Cancer Cell. 2012;22(1):51-65. DOI: 10.1016/j.ccr.2012.05.019
[113] Negi SS, Brown P. rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in
acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis. Oncotarget.
2015;6(20):18094-18104. DOI: 10.18632/oncotarget.4093
[114] Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O'Neil NJ, et al. CX-5461 is a DNA
G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours. Nature
Communications. 2017;8:14432. DOI: 10.1038/ncomms14432
[115] Peltonen K, Colis L, Liu H, Trivedi R, Moubarek MS, Moore HM, et al. A targeting
modality for destruction of RNA polymerase I that possesses anticancer activity. Cancer
Cell. 2014;25(1):77-90. DOI: 10.1016/j.ccr.2013.12.009
Control of Ribosomal RNA Transcription by Nutrients
http://dx.doi.org/10.5772/intechopen.71866
51

